Skip to search formSkip to main contentSkip to account menu

alizapride

Known as: N-((1-Allyl-2-Pyrrolidinyl)Methyl)-6-Methoxy-1H-Benzotriazole-5-Carboxamide, Alizaprida, Alizapridum 
A substituted benzamide that acts as a dopamine receptor antagonist with antiemetic properties.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Background Older patients are at high risk for experiencing Adverse Drug Events (ADEs) during hospitalization. To be able to… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND We have compared the use of alizapride, propofol, droperidol and promethazine for the prevention of spinal morphine… 
1990
1990
Two-hundred patients scheduled for elective thyroidectomy under halothane-nitrous-oxide-oxygen anaesthesia were randomly divided… 
Highly Cited
1986
Highly Cited
1986
Women (182) undergoing elective orthopaedic surgery under general anaesthesia received 100 or 200 mg alizapride, 1.25 mg… 
Highly Cited
1986
Highly Cited
1986
The ability of dopamine agonists and antagonists to compete with [3H]spiperone binding to rat striatal membrane preparations at 4… 
1985
1985
The antiemetic effect of two benzamides, metoclopramide (MCL; Paspertin) and alizapride (AZP; Vergentan), was compared in two…